Press "Enter" to skip to content

Posts tagged as “designed to protect newborns”

FDA Greenlights Merck’s RSV Shot for Newborns — Clinical Trials Showed 11.71% Rate of Serious Adverse Events, Including Death

FDA Greenlights Merck’s RSV Shot for Newborns — Clinical Trials Showed 11.71% Rate of Serious Adverse Events, Including Death

FDA Greenlights Merck’s RSV Shot for Newborns — Clinical Trials Showed 11.71% Rate of Serious Adverse Events, Including Death

June 11, 2025

by Brenda Baletti, Ph.D. The U.S. Food and Drug Administration (FDA) on Monday approved Merck’s new monoclonal antibody shot, which the company said is designed…

Categories

Breaking News: